* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *

Exelixis

genengnews.com: Genetic Engineering genengnews.com

Exelixis files application for cancer drug XL888

ibtimes.com
Oct 2, 2008 6 related
        

SOUTH SAN FRANCISCO - Biotechnology company Exelixis Inc. said Thursday it filed an investigational new drug application with the Food and Drug Administration for its cancer treatment candidate XL888. The drug is designed to...

add comment
                   

OxiGene Inks $40M Deal with Symphony Capital for VDAs

tmcnet.com
Oct 1, 2008
        

Lazard Capital Markets LLC analyst Terence Flynn wrote in a research note that the deal "addresses OxiGene's near-term capital requirements," providing funds for an ongoing pivotal trial in cancer with lead drug Zybrestat...

add comment

Thomas Weisel Partners Hosts Annual Healthcare Conference

redorbit.com
Sep 3, 2008 2 related
        

Posted on: Wednesday, 3 September 2008, 06:00 CDT Thomas Weisel Partners (NASDAQ: TWPG) (TSX: TWP), a global growth-focused investment bank, will host its Annual Healthcare Conference, September 3-5 at the Four Seasons...

add comment

CORRECTING and REPLACING Exelixis Announces September 4 Webcast of Presentation at BioCentury's...

yahoo.com
Aug 29, 2008 3 related
        

Thursday August 28, 7:42 pm ET SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--First graph, second sentence of release should read: Mr. Karbe will discuss updates to the company’s development pipeline and corporate strategy...

add comment

Red Flour Beetle's 'Selfish' Gene Sequenced

sciencedaily.com
Aug 7, 2008
        

ScienceDaily (Aug. 7, 2008) — Tracking the red flour beetle in grain storage facilities could become easier, thanks to research to identify a key gene in this grain-feeding pest. Researchers with the Agricultural Research...

add comment

Exelixis Inc. Q2 2008 Earnings Call Transcript (at Seeking Alpha)

yahoo.com
Aug 6, 2008 17 related
        

posted on: August 05, 2008 | about stocks: EXEL Executives Charles Butler - Head of IR George Scangos - CEO Frank Karbe - CFO Mike Morrissey - President of R&D Analysts Joel Sendek - Lazard Capital Markets John Sonnier -...

add comment

Exelixis Announces Second Quarter 2008 Financial Results (Business Wire)

yahoo.com
Aug 5, 2008
        

Tuesday August 5, 4:08 pm ET SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq:EXEL - News ) today reported financial results for the second quarter ended June 30, 2008. Revenues for the quarter ended June...

add comment
usda.gov: Photo: Red flour beetle. Link to photo information usda.gov

Key Red Flour Beetle Gene Sequenced

usda.gov
Jul 31, 2008
        

Determining the genetic code of a key gene could make the red flour beetle (Tribolium castaneum), a major problem.in grain storage facilities, easier to track and may offer new ways to control this pest. Click the image for...

add comment

Exelixis Announces August 8 Webcast of Presentation at the Bank of America 2008 Specialty...

yahoo.com
Jul 31, 2008
        

SOUTH SAN FRANCISCO, Calif.----Exelixis, Inc. announced today that George A. Scangos, PhD, President and Chief Executive Officer of Exelixis, will present at the Bank of America 2008 Specialty Pharmaceuticals Conference at 9:30...

add comment

Exelixis hopes for Glaxo licensing payment

ibtimes.com
Jul 28, 2008 2 related
        

SOUTH SAN FRANCISCO, Calif. - Biotechnology company Exelixis Inc. said Monday it could receive a $55 million payment if partner GlaxoSmithKline chooses to develop a potential cancer treatment. The company said it sent Glaxo...

add comment
1 2 3 4 5 next »